Literature DB >> 18676843

Loss of MLL PHD finger 3 is necessary for MLL-ENL-induced hematopoietic stem cell immortalization.

Jing Chen1, Donna A Santillan, Mark Koonce, Wei Wei, Roger Luo, Michael J Thirman, Nancy J Zeleznik-Le, Manuel O Diaz.   

Abstract

Reciprocal chromosomal translocations at the MLL gene locus result in expression of novel fusion proteins, such as MLL-ENL, associated with leukemia. The three PHD finger cassette, one of the highly conserved domains in MLL, is absent in all fusion proteins. This domain has been shown to interact with Cyp33, a cyclophilin which enhances the recruitment of histone deacetylases (HDAC) to the MLL repression domain and mediates HOX gene repression. Insertion of the third PHD finger of MLL into MLL-ENL allows the recruitment of Cyp33 and, subsequently, HDAC1 to the fusion protein. Furthermore, expression of the fusion protein with the PHD finger insertion mediates the down-regulation of the HOXC8 gene expression in a Cyp33-dependent manner. Finally, the addition of the PHD finger domain or the third PHD finger alone into MLL-ENL blocks the hematopoietic stem cell immortalization potential of the fusion protein in serial plating colony assays. Insertion of only the first and second PHD fingers has no such effect. These data support the hypothesis that the binding of Cyp33 to the MLL third PHD finger switches the MLL function from transactivation to repression. In the immortalizing MLL fusion protein, the loss of the PHD fingers, in combination with the gain of the activation domain of ENL or of other partner proteins, makes the fusion protein a constitutive transactivator. This leads to constitutive overexpression of MLL target genes that block stem cell commitment and promote stem cell renewal, probably the first step in MLL-related leukemogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18676843      PMCID: PMC2734520          DOI: 10.1158/0008-5472.CAN-07-6514

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  30 in total

1.  Dimerization of MLL fusion proteins immortalizes hematopoietic cells.

Authors:  Mary Ellen Martin; Thomas A Milne; Sebastien Bloyer; Karine Galoian; Weiping Shen; Denise Gibbs; Hugh W Brock; Robert Slany; Jay L Hess
Journal:  Cancer Cell       Date:  2003-09       Impact factor: 31.743

2.  Taspase1: a threonine aspartase required for cleavage of MLL and proper HOX gene expression.

Authors:  James J-D Hsieh; Emily H-Y Cheng; Stanley J Korsmeyer
Journal:  Cell       Date:  2003-10-31       Impact factor: 41.582

3.  Hoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalization.

Authors:  Bernd B Zeisig; Tom Milne; María-Paz García-Cuéllar; Silke Schreiner; Mary-Ellen Martin; Uta Fuchs; Arndt Borkhardt; Sumit K Chanda; John Walker; Richard Soden; Jay L Hess; Robert K Slany
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

4.  Dimerization contributes to oncogenic activation of MLL chimeras in acute leukemias.

Authors:  Chi Wai So; Min Lin; Paul M Ayton; Everett H Chen; Michael L Cleary
Journal:  Cancer Cell       Date:  2003-08       Impact factor: 31.743

5.  Proteolytic cleavage of MLL generates a complex of N- and C-terminal fragments that confers protein stability and subnuclear localization.

Authors:  James J-D Hsieh; Patricia Ernst; Hediye Erdjument-Bromage; Paul Tempst; Stanley J Korsmeyer
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

6.  Protein structure. Chaperones, paperones.

Authors:  J Sambrook; M J Gething
Journal:  Nature       Date:  1989-11-16       Impact factor: 49.962

7.  Genes on chromosomes 4, 9, and 19 involved in 11q23 abnormalities in acute leukemia share sequence homology and/or common motifs.

Authors:  T Nakamura; H Alder; Y Gu; R Prasad; O Canaani; N Kamada; R P Gale; B Lange; W M Crist; P C Nowell
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

8.  11q23 translocations split the "AT-hook" cruciform DNA-binding region and the transcriptional repression domain from the activation domain of the mixed-lineage leukemia (MLL) gene.

Authors:  N J Zeleznik-Le; A M Harden; J D Rowley
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

9.  Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia.

Authors:  Lars Bullinger; Konstanze Döhner; Eric Bair; Stefan Fröhling; Richard F Schlenk; Robert Tibshirani; Hartmut Döhner; Jonathan R Pollack
Journal:  N Engl J Med       Date:  2004-04-15       Impact factor: 91.245

10.  ENL, the gene fused with HRX in t(11;19) leukemias, encodes a nuclear protein with transcriptional activation potential in lymphoid and myeloid cells.

Authors:  J E Rubnitz; J Morrissey; P A Savage; M L Cleary
Journal:  Blood       Date:  1994-09-15       Impact factor: 22.113

View more
  28 in total

1.  ECSASB2 mediates MLL degradation during hematopoietic differentiation.

Authors:  Jingya Wang; Andrew G Muntean; Jay L Hess
Journal:  Blood       Date:  2011-12-15       Impact factor: 22.113

2.  Epigenetic dysregulation in cancer.

Authors:  Andrew G Muntean; Jay L Hess
Journal:  Am J Pathol       Date:  2009-08-28       Impact factor: 4.307

3.  Proteolytically cleaved MLL subunits are susceptible to distinct degradation pathways.

Authors:  Akihiko Yokoyama; Francesca Ficara; Mark J Murphy; Christian Meisel; Alpana Naresh; Issay Kitabayashi; Michael L Cleary
Journal:  J Cell Sci       Date:  2011-07-01       Impact factor: 5.285

Review 4.  Covalent histone modifications--miswritten, misinterpreted and mis-erased in human cancers.

Authors:  Ping Chi; C David Allis; Gang Greg Wang
Journal:  Nat Rev Cancer       Date:  2010-07       Impact factor: 60.716

Review 5.  The molecular mechanics of mixed lineage leukemia.

Authors:  R K Slany
Journal:  Oncogene       Date:  2016-02-29       Impact factor: 9.867

Review 6.  A Structural Perspective on Readout of Epigenetic Histone and DNA Methylation Marks.

Authors:  Dinshaw J Patel
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-03-01       Impact factor: 10.005

7.  Efficacy of myeloablative allogeneic hematopoietic stem cell transplantation in adult patients with MLL-ELL-positive acute myeloid leukemia.

Authors:  Tomoya Muto; Masahiro Takeuchi; Atsuko Yamazaki; Yasumasa Sugita; Shokichi Tsukamoto; Shio Sakai; Yusuke Takeda; Naoya Mimura; Chikako Ohwada; Emiko Sakaida; Nobuyuki Aotsuka; Tohru Iseki; Chiaki Nakaseko
Journal:  Int J Hematol       Date:  2015-03-11       Impact factor: 2.490

8.  Downregulation of RUNX1/CBFβ by MLL fusion proteins enhances hematopoietic stem cell self-renewal.

Authors:  Xinghui Zhao; Aili Chen; Xiaomei Yan; Yue Zhang; Fuhong He; Yoshihiro Hayashi; Yunzhu Dong; Yalan Rao; Bo Li; Rajeana M Conway; Alba Maiques-Diaz; Shannon E Elf; Nuomin Huang; Johannes Zuber; Zhijian Xiao; William Tse; Daniel G Tenen; Qianfei Wang; Wei Chen; James C Mulloy; Stephen D Nimer; Gang Huang
Journal:  Blood       Date:  2014-01-21       Impact factor: 22.113

9.  The PHD3 domain of MLL acts as a CYP33-regulated switch between MLL-mediated activation and repression .

Authors:  Sangho Park; Ute Osmers; Gayathree Raman; Rebecca H Schwantes; Manuel O Diaz; John H Bushweller
Journal:  Biochemistry       Date:  2010-08-10       Impact factor: 3.162

Review 10.  Diverse functions of PHD fingers of the MLL/KMT2 subfamily.

Authors:  Muzaffar Ali; Robert A Hom; Weston Blakeslee; Larissa Ikenouye; Tatiana G Kutateladze
Journal:  Biochim Biophys Acta       Date:  2013-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.